Institutional Ownership Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX). We have compiled data on the 255 institutions that hold shares in the stock, with a total of 57.9 Million shares, which have been reported (via 13F filing form) to have a value of $2.65 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
5,930,006
shares
|
$263 Million
1.22% of portfolio
|
Q4 2024
Added 1.18%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,758,112
shares
|
$255 Million
0.0% of portfolio
|
Q2 2024
Added 3.39%
|
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
5,498,545
shares
|
$243 Million
3.46% of portfolio
|
Q4 2024
Added 1.33%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
4,220,037
shares
|
$187 Million
0.0% of portfolio
|
Q4 2024
Added 0.09%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,331,061
shares
|
$147 Million
0.01% of portfolio
|
Q4 2024
Added 4.63%
|
|
|
Johnson & Johnson
New Brunswick, NJ |
Feb 13, 2025 Q4 2024 |
2,449,183
shares
|
$108 Million
32.24% of portfolio
|
Q3 2021
New holding
|
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,900,015
shares
|
$84.1 Million
2.74% of portfolio
|
Q4 2024
Added 2.69%
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Feb 27, 2025 Q4 2024 |
1,489,495
shares
|
$66 Million
0.36% of portfolio
|
Q4 2024
Reduced 17.92%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,392,652
shares
|
$61.7 Million
0.01% of portfolio
|
Q4 2024
Added 6.35%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,377,063
shares
|
$61 Million
0.0% of portfolio
|
Q4 2024
Added 0.17%
|
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,271,662
shares
|
$56.3 Million
1.64% of portfolio
|
Q4 2024
Reduced 7.49%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Feb 13, 2025 Q4 2024 |
1,020,333
shares
|
$45.2 Million
7.87% of portfolio
|
Q4 2024
Added 3.98%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$44.3 Million
1.7% of portfolio
|
Q4 2024
New holding
|
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
928,286
shares
|
$41.1 Million
0.02% of portfolio
|
Q4 2024
Added 61.5%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
758,690
shares
|
$33.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.69%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
738,952
shares
|
$32.7 Million
0.01% of portfolio
|
Q4 2024
Added 13.14%
|
|
|
Eversept Partners, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
678,787
shares
|
$30.1 Million
2.65% of portfolio
|
Q4 2024
Added 52.47%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
628,580
shares
|
$27.8 Million
0.0% of portfolio
|
Q4 2024
Added 8.36%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
582,327
shares
|
$25.8 Million
0.17% of portfolio
|
Q4 2024
Added 24.82%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
578,409
shares
|
$25.6 Million
0.0% of portfolio
|
Q4 2024
Added 2.28%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
576,977
shares
|
$25.5 Million
0.0% of portfolio
|
Q4 2024
Added 14.71%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
540,315
shares
|
$23.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 14.05%
|
|
|
Gratus Capital LLC
|
Jul 25, 2024 Q2 2024 |
418,346
shares
|
$18.5 Million
0.61% of portfolio
|
Q2 2024
Added 2.49%
|
|
|
683 Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
410,000
shares
|
$18.2 Million
1.13% of portfolio
|
Q4 2024
Reduced 2.38%
|
|
|
Mangrove Partners
New York, NY |
Feb 14, 2025 Q4 2024 |
395,383
shares
|
$17.5 Million
2.38% of portfolio
|
Q4 2024
Reduced 10.0%
|